Direct-to-consumer startups like Noom, Found, and Hims & Hers jumped in to fill that gap, many pivoting to prescribe compounded GLP-1s for under $200 a montha fraction of the out-of-pocket cost for the brand-name alternatives
Two systematic reviews and meta-analyzes published in 2025 narrowed that range somewhat, landing around 20 to 30% of total weight lost (Karakasis et al., Metabolism , 2025
An update on the use of tolvaptan for autosomal dominant polycystic kidney disease: Consensus statement on behalf of the ERA working group on inherited kidney disorders, the European rare kidney disease reference network and polycystic kidney disease international
According to clinical data, these are the most common issues: Nausea: Reported by up to 44% of users in some trials, often occurring shortly after an injection or dose increase
PT-141 is one of the few medications that directly addresses low sexual desire at the neurological level